SONATA THERAPEUTICS

What this means for you

This application is over — abandoned 16 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97420640

Mark type

Stylized text

Filed

20 May 2022

Abandoned

16 Jun 2025

Attorney of record

Christina M. Licursi

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer
• Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Owner

• Sonata Therapeutics, Inc., Watertown, MA, US

Prosecution history

• 01 Jul 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 01 Jul 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 13 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 13 Mar 2025 — NON-FINAL ACTION E-MAILED
• 13 Mar 2025 — NON-FINAL ACTION WRITTEN
• 19 Nov 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 02 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 02 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 02 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 29 Mar 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 28 Sept 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 28 Sept 2023 — LETTER OF SUSPENSION E-MAILED
• 28 Sept 2023 — SUSPENSION LETTER WRITTEN
• 23 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 23 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE